SCIENCE@home

Leveraging polysaccharide-derived nanocarriers to open new horizons in oral vaccine activation

Siyuan Wang,Tao Jiang,Min Jiang,Yang-Bao Miao

Published 2025 in Materials Today Bio

ABSTRACT

Oral vaccines represent a transformative approach in immunization, offering non-invasive administration, mucosal immune activation, and improved patient compliance. However, their clinical translation is hindered by multiple physiological barriers, such as gastric degradation, enzymatic hydrolysis, and inefficient antigen uptake in gut-associated lymphoid tissues. This review explores the emerging role of polysaccharide-derived nanocarriers, particularly those inspired by traditional Chinese medicine (TCM), in addressing these challenges. We discuss how these biocompatible and biodegradable materials can be engineered to enhance antigen stability, promote targeted delivery to Peyer's patches, and stimulate robust mucosal and systemic immune responses. Key design principles—such as bioadhesion, structural tunability, and immunomodulatory capacity—are highlighted across various carrier systems. Moreover, we examine multifunctional delivery strategies, including co-delivery of adjuvants, pH-responsive release, and mucoadhesive platforms. Special emphasis is placed on the potential integration of polysaccharide nanocarriers into next-generation oral mRNA and nucleic acid vaccine technologies. These insights underscore the promise of polysaccharide-based nanotechnology as a cornerstone for future oral vaccine platforms, paving the way for non-invasive, scalable, and immunologically effective vaccination strategies.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-100 of 245 references · Page 1 of 3

123
Next

CITED BY